132 related articles for article (PubMed ID: 8877013)
1. Protein tyrosine kinase activity in 350 T1/T2, N0/N1 breast cancer. Preliminary results.
Bolla M; Rostaing-Puissant B; Bottari SP; Chedin M; Marron-Charriere J; Colonna M; Berland E; Chambaz E
Breast Cancer Res Treat; 1996; 39(3):327-34. PubMed ID: 8877013
[TBL] [Abstract][Full Text] [Related]
2. Prognostic assessment of PTK activity in T1-T2, N0-N1, M0 breast cancer: a multicentric retrospective study.
Rostaing-Puissant B; Chambaz EM; Romain S; Spyratos F; Daver A; Jourdan ML; Descotes F; Colonna M; Martin PM; Bolla M
Breast Cancer Res Treat; 2002 Jul; 74(2):135-41. PubMed ID: 12186374
[TBL] [Abstract][Full Text] [Related]
3. Protein tyrosine kinase activity as a prognostic parameter in breast cancer, a pilot study.
Bolla M; Rostaing-Puissant BR; Chedin M; Souvignet C; Marron-Charriere J; Colonna M; Berland E; Chambaz EM
Breast Cancer Res Treat; 1993; 26(3):283-7. PubMed ID: 8251653
[TBL] [Abstract][Full Text] [Related]
4. Characterization of protein tyrosine kinases from human breast cancer: involvement of the c-src oncogene product.
Ottenhoff-Kalff AE; Rijksen G; van Beurden EA; Hennipman A; Michels AA; Staal GE
Cancer Res; 1992 Sep; 52(17):4773-8. PubMed ID: 1380891
[TBL] [Abstract][Full Text] [Related]
5. Protein tyrosine kinase activity in breast cancer and its relation to prognostic indicators.
Kopreski MS; Witters L; Brennan WA; Buckwalter EA; Chinchilli VM; Demers LM; Lipton A
Anticancer Res; 1996; 16(5B):3037-41. PubMed ID: 8920763
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of cytosolic tyrosine kinase activity in 249 node-positive breast cancer patients.
Romain S; Chinot O; Klijn JG; van Putten WL; Guirou O; Look M; Martin PM; Foekens JA
Br J Cancer; 1994 Aug; 70(2):304-8. PubMed ID: 8054279
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of quantitative cytometry in a series of 415 T1T2/N0N1/M0 breast cancer patients--preliminary results.
Bolla M; Seigneurin D; Winckel P; Marron-Charrière J; Panh MH; Pasquier D; Ch-edin M; Payan R; Merlin F; Colonna M
Eur J Cancer; 1996 Sep; 32A(10):1680-5. PubMed ID: 8983274
[TBL] [Abstract][Full Text] [Related]
8. Identification of cytosolic protein tyrosine kinases of human prostate by renaturation after SDS/PAGE.
Durocher Y; Chapdelaine A; Chevalier S
Biochem J; 1992 Jun; 284 ( Pt 3)(Pt 3):653-8. PubMed ID: 1622386
[TBL] [Abstract][Full Text] [Related]
9. Protein tyrosine kinase activity assays.
Hawes BE; van Biesen T
Curr Protoc Pharmacol; 2001 May; Chapter 3():Unit3.5. PubMed ID: 21965067
[TBL] [Abstract][Full Text] [Related]
10. Lack of prognostic value of epidermal growth factor receptor in a series of 229 T1/T2, N0/N1 breast cancers, with well defined prognostic parameters.
Bolla M; Chedin M; Colonna M; Marron-Charrière J; Rostaing-Puissant B; Pasquier D; Panh MH; Winckel P; Chambaz EM
Breast Cancer Res Treat; 1994; 29(3):265-70. PubMed ID: 8049460
[TBL] [Abstract][Full Text] [Related]
11. Hydrophobic Core Variations Provide a Structural Framework for Tyrosine Kinase Evolution and Functional Specialization.
Mohanty S; Oruganty K; Kwon A; Byrne DP; Ferries S; Ruan Z; Hanold LE; Katiyar S; Kennedy EJ; Eyers PA; Kannan N
PLoS Genet; 2016 Feb; 12(2):e1005885. PubMed ID: 26925779
[TBL] [Abstract][Full Text] [Related]
12. Protein tyrosine phosphatases as novel targets in breast cancer therapy.
Nunes-Xavier CE; Martín-Pérez J; Elson A; Pulido R
Biochim Biophys Acta; 2013 Dec; 1836(2):211-26. PubMed ID: 23756181
[TBL] [Abstract][Full Text] [Related]
13. Comparative characterization of receptor and non-receptor associated protein tyrosine kinases.
Srivastava AK; Chiasson JL
Biochim Biophys Acta; 1989 Jun; 996(1-2):13-8. PubMed ID: 2736256
[TBL] [Abstract][Full Text] [Related]
14. Protein tyrosine kinases: structure, substrate specificity, and drug discovery.
al-Obeidi FA; Wu JJ; Lam KS
Biopolymers; 1998; 47(3):197-223. PubMed ID: 9817025
[TBL] [Abstract][Full Text] [Related]
15. Effects of testosterone and 17β‑estradiol on angiotensin‑induced changes in tyrosine kinase activity in the androgen‑independent human prostate cancer cell line, DU145.
Domińska K; Kowalski A; Ochędalski T; Rębas E
Int J Mol Med; 2017 Nov; 40(5):1573-1581. PubMed ID: 28949385
[TBL] [Abstract][Full Text] [Related]
16. Expression profiles of protein tyrosine kinase genes in human embryonic stem cells.
Son MY; Kim J; Han HW; Woo SM; Cho YS; Kang YK; Han YM
Reproduction; 2008 Oct; 136(4):423-32. PubMed ID: 18583472
[TBL] [Abstract][Full Text] [Related]
17. Standardization of an enzyme-linked immunosorbent assay for the determination of protein tyrosine kinase activity.
Schraag B; Staal GE; Adriaansen-Slot SS; Salden M; Rijksen G
Anal Biochem; 1993 Jun; 211(2):233-9. PubMed ID: 7686354
[TBL] [Abstract][Full Text] [Related]
18. Screening of protein tyrosine kinases activated during neural induction in Xenopus.
Dupont H; Audigier S; Chevalier S
Anal Biochem; 1996 May; 237(1):42-8. PubMed ID: 8660535
[TBL] [Abstract][Full Text] [Related]
19. Advances in studies of tyrosine kinase inhibitors and their acquired resistance.
Jiao Q; Bi L; Ren Y; Song S; Wang Q; Wang YS
Mol Cancer; 2018 Feb; 17(1):36. PubMed ID: 29455664
[TBL] [Abstract][Full Text] [Related]
20. Non-receptor cytosolic protein tyrosine kinases from various rat tissues.
Elberg G; Li J; Leibovitch A; Shechter Y
Biochim Biophys Acta; 1995 Nov; 1269(3):299-306. PubMed ID: 7495884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
